Boothbay Fund Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,937
| Closed | -$72K | – | 2356 |
|
|
2022
Q2 | $72K | Hold |
13,937
| – | – | ﹤0.01% | 1770 |
|
|
2022
Q1 | $143K | Hold |
13,937
| – | – | ﹤0.01% | 1624 |
|
|
2021
Q4 | $157K | Sell |
13,937
-1,679
| -11% | -$18.9K | ﹤0.01% | 1408 |
|
|
2021
Q3 | $319K | Sell |
15,616
-4,035
| -21% | -$82.4K | 0.01% | 1084 |
|
|
2021
Q2 | $491K | Buy |
19,651
+2,070
| +12% | +$51.7K | 0.02% | 884 |
|
|
2021
Q1 | $503K | Buy |
+17,581
| New | +$503K | 0.02% | 762 |
|